ClinicalTrials.gg
RecruitingNCT06511310Updated Sep 4, 2025

Exercise, Brain Activity, and Weight Maintenance

An interventional study of Exercise in Obesity, Weight Gain and Bariatric Surgery Candidate, sponsored by Joslin Diabetes Center. Recruiting at 1 site in United States. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-09-04.

Sponsored by Joslin Diabetes Center · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Primary completion was expected by Jul 2026, 4 months ago, but the record still lists the study as recruiting.
Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Study summary

This study aims to explore how HIIT influences brain function, neural and molecular pathways related to weight control, setting the stage for future obesity intervention research.

Read the detailed description

This study will include adults aged 18-70 years with a BMI >19 kg/m², both with and without prior bariatric surgery. Those with bariatric surgery must have experienced clinically significant weight regain (>10% of maximum weight lost) within 1 to 5 years post-surgery.

Participants will complete three initial clinical visits before beginning a 12-week high-intensity interval training (HIIT) program, followed by three post-training clinical visits. During visit 1, participants will undergo anthropometric assessments, baseline blood draw, oral glucose tolerance test, psychometric evaluations, and complete an MRI safety screening. At visit 2, participants will complete a resting metabolic rate assessment and a VO₂peak test. During visit 3, participants will have another baseline blood draw and undergo a functional MRI (fMRI).

The HIIT program will consist of four weekly 28-minute sessions conducted at the Joslin Diabetes and at home. Each exercise session will include a 3-minute warm-up, six rounds of 40 seconds high-intensity followed by 3 minutes of moderate intensity, and will conclude with a 3-minute cool-down.

After completing the 12-week program, participants will return for clinical visits 4-6, repeating all baseline assessments.

02

Conditions studied

  • Obesity
  • Weight Gain
  • Bariatric Surgery Candidate
  • Appetitive Behavior
03

In context

Obesity

11,522 studies on the registry are indexed under Obesity; 2,033 are open to participants now.

This study's planned enrollment of 15 is below the median of 67 across 9,006 interventional studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

Joslin Diabetes Center is the lead sponsor of 80 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18-70 years
  • (BMI) >19 kg/m2 and body weight\< 250kg
  • Participants must have experienced a weight regain, defined as over 10% of their maximum weight lost, within 1 to 5 years following their bariatric surgery. They will be asked to self-report their weight loss history. Participants must also provide the operative report from their bariatric surgery for reference.
  • In good general health with no conditions that could influence the outcome of the trial, and in the judgment of the investigator is a good candidate for the study based on review of available medical history, physical examination and clinical laboratory evaluations
  • Willing to adhere to the protocol requirements for the duration of the study

Exclusion criteria

Exclusion Criteria:

  • Type 1 diabetes mellitus
  • Peripheral neuropathy with insensate feet
  • Recent blood donation within the last 2 months
  • Use of beta-blockers
  • Current pregnancy or breastfeeding
  • Active Heart or lung disease
  • Severe hypertension (systolic >160 mmHg or diastolic >90 mmHg)
  • Inability to exercise for any reason
  • Any known to exercise testing based on current ACSM guidelines
  • MRI contraindications, such as presence of pacemakers, aneurysm clips, artificial heart valves, ear implants, metal fragments, or foreign objects in the eyes, skin, or body
  • Known presence of a structural brain lesion (e.g. tumor, cortical infarct)
  • Presence of another neurologic disorder, which could impact findings (e.g. multiple sclerosis)
  • History of cardiovascular disease, stroke, congestive heart failure
  • Active hematological, renal, pulmonary or hepatic disorders
  • Active treatment for cancer
  • A history of active alcohol or substance abuse
  • Any significant systemic illness or unstable medical condition which could lead to difficulty complying with the study protocol
  • History of claustrophobia and inability to tolerate an MRI
  • Body weight >250kgr and largest body diameter of 70cm as there is a certain weight and diameter limit of the MRI scanner
  • Unwilling or unable to return for study visits, undergo neuropsychological testing and MRI imaging
  • Left-handedness
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Exercise Training

    Subjects will complete a supervised high-intensity interval training program for 12 weeks, including four weekly training sessions. The training session will include a 3 minute warm-up followed by six 40 second bouts of high intensity (85-95% of VO2peak) with 3 minutes moderate intensity (45-55% of VO2peak) between each bout of high intensity, concluding with a 3 minute cool-down. Each participant's target heart rate will be specific to them, calculated from the exercise test completed during Visit 1.

    Other: Exercise

Interventions

  • OtherExercise

    High Intensity Exercise

06

What researchers measure

Primary outcomes

  1. Changes in connectivity between brain areas following exercise training by using resting state functional MRI.

    Time frame: Evaluation of changes in brain function by fMRI before and after 12 weeks of exercise training.

Secondary outcomes

  1. Changes in appetitive behavior.

    Subjects will be evaluated with Three Factor Eating Questionnaire (TFEQ).

    Time frame: Evaluation of changes in hunger before and after 12 weeks of exercise training.

  2. Changes in mood.

    Subjects will be evaluated with Beck Depression Inventory II (BDI-II) to assess for depressive symptoms.

    Time frame: Evaluation of changes in mood before and after 12 weeks of exercise training.

  3. Degree of changes in miRNA profiling of circulating exosomes in blood samples.

    Changes in circulating exosome miRNAs will be measured using next-generation sequencing (NGS) and reported as normalized counts or fold changes relative to baseline.

    Time frame: Evaluation of changes in miRNA before and after 12 weeks of exercise training.

  4. Changes in cognitive function.

    Evaluation using mini cognitive test.

    Time frame: Changes in cognition function before and after 12 weeks of HIIT.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06511310
Lead sponsor
Joslin Diabetes Center
Collaborators
Nutrition Obesity Research Center
Responsible party
Sponsor
First posted
Jul 19, 2024
Start date
Sep 15, 2025 (estimated)
Primary completion
Jul 1, 2026 (estimated)
Completion
Jul 1, 2027 (estimated)
Last update
Sep 4, 2025

Study contacts

Maria Vamvini, MD
Contact
Maria.Vamvini@joslin.harvard.edu
617-309-2400
Laura Simpson, MS
Contact
laura.simpson@joslin.harvard.edu
617-735-3924
Maria Vamvini, MD
principal investigator · Joslin Diabetes Center

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion